Literature DB >> 20639913

Stroke: Measuring disease-free life after thrombolysis.

Susan C Fagan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639913     DOI: 10.1038/nrneurol.2010.79

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  6 in total

1.  Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.

Authors:  S C Fagan; L B Morgenstern; A Petitta; R E Ward; B C Tilley; J R Marler; S R Levine; J P Broderick; T G Kwiatkowski; M Frankel; T G Brott; M D Walker
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

2.  Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke.

Authors:  Keun-Sik Hong; Jeffrey L Saver
Journal:  Stroke       Date:  2010-02-04       Impact factor: 7.914

3.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Functional outcome 3 months after stroke predicts long-term survival.

Authors:  Marie Eriksson; Bo Norrving; Andreas Terént; Birgitta Stegmayr
Journal:  Cerebrovasc Dis       Date:  2008-03-17       Impact factor: 2.762

5.  Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies.

Authors:  Karsten Bruins Slot; Eivind Berge; Paul Dorman; Steff Lewis; Martin Dennis; Peter Sandercock
Journal:  BMJ       Date:  2008-01-29

6.  A user's guide to the NINDS rt-PA stroke trial database.

Authors:  Robert J Dachs; John H Burton; Jeremy Joslin
Journal:  PLoS Med       Date:  2008-05-20       Impact factor: 11.069

  6 in total
  1 in total

1.  Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning.

Authors:  Ok-Nam Bae; Krishnamurthy Rajanikant; Jiangyong Min; Jeremy Smith; Seung-Hoon Baek; Kelsey Serfozo; Siamak Hejabian; Ki Yong Lee; Mounzer Kassab; Arshad Majid
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.